Ergotalkaloids for treating senile dementia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544346, A61K 3148, C07D51902

Patent

active

047374993

ABSTRACT:
An ergot 5'S-(2R-butyl) peptide alkaloid and its acid addition salts is a useful pharmaceutical for use as a prolactin secretion inhibitor, for increasing vigilance or for the treatment of senile dementia, hypertension, or stroke.

REFERENCES:
patent: 4000139 (1976-12-01), Stutz et al.
patent: 4091099 (1978-05-01), Fehr et al.
patent: 4138565 (1979-02-01), Ehrhardt et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ergotalkaloids for treating senile dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ergotalkaloids for treating senile dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergotalkaloids for treating senile dementia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1429539

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.